Regeneron Study Site — New York, New York

Regeneron Study Site is a clinical research site located in New York, New York, United States 10016.

Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Regeneron Study Site has participated in 48 clinical trials.

Therapeutic areas: Atopic Dermatitis, Relapsed Multiple Myeloma, Refractory Multiple Myeloma.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regeneron Study Site?

Regeneron Study Site has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regeneron Study Site conducted?

Regeneron Study Site has 48 clinical trials on record. Their work covers Atopic Dermatitis, Relapsed Multiple Myeloma, Refractory Multiple Myeloma.

Is Regeneron Study Site accredited by Crixeo Clinical Trials?

Regeneron Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regeneron Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.